Skip to content

Apotheker Bosmans Kristien

Active
General partnershipfounded 201214 yrs activeWitgerlaan 7, 1785 Merchtem, BelgiumKBO/BCE: BE 0844.653.234
Summary

Apotheker Bosmans Kristien has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €75k and a net result of €18k. Equity is growing by ~5.1% per year across the filed fiscal years. Its solvency ranks better than 67% of 18280 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
82 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability85▼-3
Solvency80▼-20
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6k at 30 days acceptable
Liquidity ample (current ratio 2.16 against 4.26 in 2024; short-term debt: 45.3% and cash: 86.1% of total assets), and 45.5% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
54.5%
Return on assets
12.9%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 14 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-08-2026, 6 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
6 d late
2024
1 d late
2023
14 d late
2022
4 d early
2021
22 d late
2020
24 d late
2019
10 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€75k▼ 29.5%
2024 · €107k
2018: €64k 2019: €84k 2020: €85k 2021: €91k 2022: €81k 2023: €106k 2024: €107k
2018 → 2025
Total assets
€138k▼ 0.8%
2024 · €139k
2018: €73k 2019: €94k 2020: €119k 2021: €118k 2022: €113k 2023: €136k 2024: €139k
2018 → 2025
Net result
€18k▼ 15.7%
2024 · €21k
2018: €10k 2019: €20k 2020: €19k 2021: €18k 2022: €12k 2023: €34k 2024: €21k
2018 → 2025
Working capital
€72k▼ 30.6%
2024 · €104k
2018: €65k 2019: €85k 2020: €85k 2021: €89k 2022: €80k 2023: €106k 2024: €104k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€91k-€81k▼ 10.8%€106k▲ 30.1%€107k▲ 0.8%€75k▼ 29.5%
Operating result€27k-€20k▼ 27.3%€50k▲ 153%€33k▼ 34.6%€28k▼ 14.7%
Net result€18k-€12k▼ 32.3%€34k▲ 182%€21k▼ 38.7%€18k▼ 15.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20k€40k€60kOperating result 2021: €27k€27kNet result 2021: €18k€18kOperating result 2022: €20k€20kNet result 2022: €12k€12kOperating result 2023: €50k€50kNet result 2023: €34k€34kOperating result 2024: €33k€33kNet result 2024: €21k€21kOperating result 2025: €28k€28kNet result 2025: €18k€18k20212022202320242025€0€20k€40k€60kOperating result 2023: €50k€50kNet result 2023: €34k€34kOperating result 2024: €33k€33kNet result 2024: €21k€21kOperating result 2025: €28k€28kNet result 2025: €18k€18k202320242025
The operating result has fallen two years in a row; 2025 is 15% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €138k
Fixed assets €3k ▲ 7.3%
Current assets €135k ▼ 0.9%
Equity and liabilities €138k
Equity €75k ▼ 29.5%
Debt €63k ▲ 93.5%
Debt's share of the balance-sheet total rises from 23.3% to 45.5%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€29k
2024 · €34k
Cash flow
€19k
2024 · €22k
Current ratio
2.16
2024 · 4.26
Debt to equity
0.83
2024 · 0.30
ROE
23.6%
2024 · 19.8%
ROA
12.9%
2024 · 15.1%
Interest coverage
56.32
2024 · 53.05
Debt ≤ 1 year
€63k
2024 · €32k
Income taxes
€10k
2024 · €11k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet Code20242025
Assets
Total assets20/58€139k€138k
Fixed assets21/28€3k€3k
Tangible fixed assets22/27€3k€3k
Furniture and vehicles24€3k€3k
Current assets29/58€136k€135k
Amounts receivable within one year40/41€899€14k
Trade receivables40€0€12k
Other amounts receivable41€899€1k
Cash at bank and in hand54/58€134k€119k
Deferred charges and accrued income490/1€1k€2k
Equity and liabilities
Total equity and liabilities10/49€139k€138k
Equity10/15€107k€75k
Contributions10/11€1k€1k=
Reserves13€106k€74k
Non-distributable reserves130/1€100€100=
Reserves not available under the articles1311€100€100=
Distributable reserves133€106k€74k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€32k€63k
Amounts payable within one year42/48€32k€63k
Trade debts44€2k€2k
Suppliers440/4€2k€2k
Taxes, remuneration and social security45€5k€8k
Taxes450/3€5k€6k
Remuneration and social security454/9-€2k
Other amounts payable47/48€24k€53k
Accrued charges and deferred income492/3€502€281
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€759€866
Other operating charges640/8€148€227
Gross operating margin9900€34k€29k
Operating profit (loss)9901€33k€28k
Financial charges65/66B€633€513
Recurring financial charges65€633€513
Profit (loss) for the period before taxes9903€32k€27k
Income taxes67/77€11k€10k
Profit (loss) for the period9904€21k€18k
Profit (loss) for the period to be appropriated9905€21k€18k
Appropriation of the result
Profit (loss) to be appropriated9906€21k€18k
Transfer from equity791/2€20k€49k
Transfer to equity691/2€21k€18k
To other reserves6921€21k€18k
Profit to be distributed694/7€20k€49k
Return on contributions (dividend)694€20k€49k

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
06-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 6 days late
2025
01-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 1 day late
2024
14-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 14 days late
2023
31-12
Financial Highest result since 2018net €34k ▲182%
Operating result €50k, net result €34k, both a record.
31-12
Financial Equity above €100kEq €106k ▲30.1%
6 profitable years in a row build equity to €106k.
27-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
22-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 22 days late
2021
24-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 24 days late
2020
10-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 10 days late
2019
20-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 20 days late
2018
24-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 24 days late
2017
21-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 21 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Merchtem · 1 establishment unit since 2012
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Witgerlaan 71785 Merchtem
Ground area
671 m²
Building footprint
190 m²
Volume, LiDAR
1,199 m³
Parcel 23028A0081/00Z008, Flanders · tallest building 10.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Apotheker Bosmans Kristien
Witgerlaan 7, 1785 MerchtemRetail sale of pharmaceutical products
since 20122.209.660.592
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23028A0081/00Z008 Flanders 671 m² 1 · 190 m² 10.2 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,198 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formGeneral partnership
Founded23-03-2012
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.

Contact details

1 entry
Phone:0472/51.61.47
Establishment Merchtem 2.209.660.592